What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Heart failure
- Cardiology
The scientist’s investigation covers issues in Heart failure, Internal medicine, Cardiology, Heart disease and Ejection fraction.
He studies Heart failure, namely Cardiac resynchronization therapy.
His studies examine the connections between Internal medicine and genetics, as well as such issues in Endocrinology, with regards to Idiopathic dilated cardiomyopathy.
His Cardiology study frequently intersects with other fields, such as Diastole.
His Heart disease study also includes fields such as
- Mitral regurgitation, which have a strong connection to Mitral valve,
- Ambulatory which intersects with area such as Decompensation.
His Ejection fraction research incorporates themes from Doppler echocardiography, Multivariate analysis, Clinical endpoint, Sinus rhythm and Pulmonary wedge pressure.
His most cited work include:
- Cardiac Resynchronization in Chronic Heart Failure (4136 citations)
- 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the International Society for Heart and Lung Transplantation (3376 citations)
- Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. (2792 citations)
What are the main themes of his work throughout his whole career to date?
William T. Abraham mainly focuses on Heart failure, Internal medicine, Cardiology, Ejection fraction and Intensive care medicine.
His research investigates the connection between Heart failure and topics such as Hemodynamics that intersect with problems in Ambulatory.
His research in the fields of Cardiac resynchronization therapy, Natriuretic peptide and Hazard ratio overlaps with other disciplines such as In patient.
William T. Abraham has included themes like Electrocardiography and Quality of life in his Cardiac resynchronization therapy study.
His study in Cardiology focuses on QRS complex, Mitral regurgitation, Ventricular remodeling, Pulmonary artery and MitraClip.
The various areas that William T. Abraham examines in his Ejection fraction study include Clinical endpoint and Atrial fibrillation.
He most often published in these fields:
- Heart failure (76.80%)
- Internal medicine (73.26%)
- Cardiology (64.96%)
What were the highlights of his more recent work (between 2016-2021)?
- Heart failure (76.80%)
- Internal medicine (73.26%)
- Cardiology (64.96%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Heart failure, Internal medicine, Cardiology, Ejection fraction and In patient.
His biological study focuses on Cardiac resynchronization therapy.
His Cardiac resynchronization therapy research focuses on QRS complex and how it connects with Left bundle branch block.
He frequently studies issues relating to Clinical endpoint and Cardiology.
His study focuses on the intersection of Ejection fraction and fields such as Positive airway pressure with connections in the field of Central sleep apnea.
His Intensive care medicine research is multidisciplinary, incorporating perspectives in Shock and Cardiogenic shock.
Between 2016 and 2021, his most popular works were:
- Effect of Ularitide on Cardiovascular Mortality in Acute Heart Failure (176 citations)
- Pulmonary Artery Pressure-Guided Management of Patients With Heart Failure and Reduced Ejection Fraction (85 citations)
- Impact of Practice-Based Management of Pulmonary Artery Pressures in 2000 Patients Implanted with the CardioMEMS Sensor (70 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Heart failure
- Cardiology
William T. Abraham spends much of his time researching Heart failure, Internal medicine, Cardiology, Ejection fraction and Randomized controlled trial.
His Heart failure study integrates concerns from other disciplines, such as Hazard ratio, Hemodynamics, Clinical trial and Intensive care medicine.
His research on Cardiology often connects related areas such as Prospective cohort study.
His Ejection fraction research includes themes of Clinical endpoint, Blood pressure, Atrial fibrillation and Emergency medicine.
His Randomized controlled trial study also includes fields such as
- Cohort which intersects with area such as Coronary artery disease and Cardiomyopathy,
- Subgroup analysis together with Cardiac contractility modulation,
- Telemedicine together with Emergency department and Preload.
His Cardiac resynchronization therapy research is multidisciplinary, relying on both Disease progression and Mass index.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
